nach oben

Erschienen in:

2013 | OriginalPaper | Buchkapitel

33. Pilzinfektionen

verfasst von : Werner Mendling, Prof. Dr. med., Ioannis Mylonas, Andreas Schulze, Prof. Dr. med., Anne Hilgendorff, PD Dr. med.

Erschienen in: Infektionserkrankungen der Schwangeren und des Neugeborenen

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Vulvovaginalkandidose ist eine Infektion mit Pilzen der Gattung Candida der östrogenisierten Vagina und des Vestibulums, die am äußeren Genitale, der Scheide, der Interkruralregion sowie der Perianalregion anzutreffen ist. Im deutschen Sprachraum ist die Bezeichnung Vulvovaginalkandidose oder Candida albicans – Vulvovaginitis üblich (Mendling 2006). Häufig wird auch der Begriff Candidiasis verwendet, v. a. wegen der weiten Verbreitung und Nutzung im angloamerikanischen Sprachraum. Allerdings sollte die Änderung „-iasis“ für eine Infektion mit Parasiten genutzt werden (Mendling 2006).

Aleck KA, Bartley DL (1997) Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient. Am J Med Genet 72(3):253–256PubMedCrossRef

Amir LH, Garland SM, Dennerstein L, Farish SJ (1996) Candida albicans: is it associated with nipple pain in lactating women? Gynecol Obstet Invest 41(1):30–34PubMedCrossRef

Anderson MR, Klink K, Cohrssen A (2004) Evaluation of vaginal complaints. JAMA 291(11):1368–1379PubMedCrossRef

Babula O, Lazdane G, Kroica J, Linhares IM, Ledger WJ, Witkin SS (2005) Frequency of interleukin-4 (IL-4) -589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannose-binding lectin in women with recurrent vulvovaginal candidiasis. Clin Infect Dis 40(9):1258–1262PubMedCrossRef

Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA (1986) Fungal colonization in the very low birth weight infant. Pediatrics 78(2):225–232PubMed

Benjamin Jr. DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, Poole K, Laptook A, Goldberg R (2006) Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117:84–92PubMedCrossRef

Bishop JA, Chase N, Lee R, Kurtzman CP, Merz WG (2008) Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits. Journal of clinical microbiology 46(10):3498–3500PubMedCrossRef

Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J (1986) Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study. Br J Obstet Gynaecol 93(1):79–81PubMedCrossRef

Blaschke-Hellmessen R (1968) Epidemiological studies of the occurrence of yeasts in children and their mothers. Mykosen 11(9):611–616PubMedCrossRef

Blaschke-Hellmessen R (1972) Experimental studies on the epidemiology of saccharomycoses in infants and small children. Mykosen 15(1):23–26PubMedCrossRef

Blaschke-Hellmessen R (1977) Use of liquid enrichment cultures for the detection of Candida albicans and other incidentally pathogenic yeasts. Z Med Lab Diagn 18(1):34–37PubMed

Blaschke-Hellmessen R (1998) Vertical transmission of Candida and its consequences. Mycoses 41(Suppl 2):31–36PubMedCrossRef

Blaschke-Hellmessen R, Henker J, Futschik M (1991) Ergebnisse mykologischer Untersuchungen gespendeter Frauenmilch. Kinderärztl Prax 59:77–80PubMed

Blaschke-Hellmessen R, Schnell JD, Spitzbart H, Mendling W (2006) Subpartale Übertragung von Sprosspilzen von der Mutter auf das Kind. Frauenarzt 47:714–723

Bohannon NJ (1998) Treatment of vulvovaginal candidiasis in patients with diabetes. Diabetes Care 21(3):451–456PubMedCrossRef

Briggs GG, Freeman RK, Yaffe SJ (1998) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 5. Aufl. Lippincott Williams and Wilkins,

Buch A, Skytte Christensen E (1982) Treatment of vaginal candidosis with natamycin and effect of treating the partner at the same time. Acta Obstet Gynecol Scand 61(5):393–396PubMedCrossRef

Chaim W, Foxman B, Sobel JD (1997) Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype. J Infect Dis 176(3):828–830PubMedCrossRef

Chapman RL (2007) Prevention and treatment of Candida infections in neonates. Semin Perinatol 31:39–46PubMedCrossRef

Cohen L (1985) Treatment of vaginal candidosis using clotrimazole vaginal cream: single dose versus 3-day therapy. Curr Med Res Opin 9(8):520–523PubMedCrossRef

Corsello S, Spinillo A, Osnengo G, Penna C, Guaschino S, Beltrame A, Blasi N, Festa A (2003) An epidemiological survey of vulvovaginal candidiasis in Italy. Eur J Obstet Gynecol Reprod Biol 110(1):66–72PubMedCrossRef

Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA (1998) Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol 178:374–380PubMedCrossRef

Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin Jr DK (2006) The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 118:717–722PubMedCrossRef

Czeizel AE, Rockenbauer M (1999) A lower rate of preterm birth after clotrimazole therapy during pregnancy. Paediatr Perinat Epidemiol 13(1):58–64PubMedCrossRef

Czeizel AE, Fladung B, Vargha P (2004) Preterm birth reduction after clotrimazole treatment during pregnancy. European journal of obstetrics, gynecology, and reproductive biology 116(2):157–163PubMedCrossRef

Dennerstein GJ, Ellis DH (2001) Oestrogen, glycogen and vaginal candidiasis. Aust N Z J Obstet Gynaecol 41(3):326–328PubMedCrossRef

Dixon PN, Warin RP, English MP (1972) Alimentary Candida albicans and napkin rushes. Br J Dermatol 86:458–462PubMedCrossRef

Donders GG, Prenen H, Verbeke G, Reybrouck R (2002) Impaired tolerance for glucose in women with recurrent vaginal candidiasis. Am J Obstet Gynecol 187(4):989–993PubMedCrossRef

Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R, Stalpaert M, Vereecken A, Van Eldere J (2008) Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Am J Obstet Gynecol 199(6):613.e1–9PubMedCrossRef

Donders GG, Babula O, Bellen G, Linhares IM, Witkin SS (2008) Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis. BJOG 115(10):1225–1231PubMedCrossRef

Eckert LO, Hawes SE, Stevens CE, Koutsky LA, Eschenbach DA, Holmes KK (1998) Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol 92(5):757–765PubMedCrossRef

Ehrstrom S, Kornfeld D, Rylander E (2007) Perceived stress in women with recurrent vulvovaginal candidiasis. J Psychosom Obstet Gynaecol 28(3):169–176PubMedCrossRef

Ellepola AN, Morrison CJ (2005) Laboratory diagnosis of invasive candidiasis. J Microbiol 43:65–84PubMed

Fairchild KD, Tomkoria S, Sharp EC, Mena FV (2002) Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J 21:39–43PubMedCrossRef

Faix RG (1992) Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection. Pediatr Infect Dis J 11:88–93PubMedCrossRef

Faix RG, Kovarik SM, Shaw TR, Johnson RV (1989) Mucocutaneous and invasive candidiasis among very low birth weight (less than 1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 83:101–107PubMed

Flemmer AW, Yilmaz E, Mittal R, Muller-Edenborn B, Haas A, Holzinger A, Schulze A (2008) Malassezia furfur colonising the respiratory tract of mechanically ventilated neonates. Z Geburtshilfe Neonatol 212:22–26PubMedCrossRef

Francis-Morrill J, Heinig MJ, Pappagianis D, Dewey KG (2004) Diagnostic value of signs and symptoms of mammary candidosis among lactating women. J Hum Lact 20(3):288–295 (quiz 296–299)PubMedCrossRef

Friebe-Hoffmann U, Bender DP, Sims CJ, Rauk PN (2000) Candida albicans chorioamnionitis associated with preterm labor and sudden intrauterine demise of one twin. A case report. J Reprod Med 45:354–356PubMed

Friedman S, Richardson SE, Jacobs SE, O’Brien K (2000) Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J 19:499–504PubMedCrossRef

Friese K, Mörike K, Neumann G, Windorfer A (2009) Arzneimittel in der Schwangerschaft und Stillzeit: Ein Leitfaden für Ärzte und Apotheker, 7. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart

Friese K, Schäfer A, Hof H (2003) Infektionskrankheiten in Gynäkologie und Geburtshilfe. Springer, Berlin

Goswami R, Dadhwal V, Tejaswi S, Datta K, Paul A, Haricharan RN, Banerjee U, Kochupillai NP (2000) Species-specific prevalence of vaginal candidiasis among patients with diabetes mellitus and its relation to their glycaemic status. J Infect 41(2):162–166PubMedCrossRef

Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA, Kochupillai N (2006) Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J Infect 52(2):111–117PubMedCrossRef

Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC (2011) Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Medical mycology : official publication of the International Society for Human and Animal Mycology 49(1):16–25CrossRef

Hay P, Czeizel AE (2007) Asymptomatic trichomonas and candida colonization and pregnancy outcome. Best Pract Res Clin Obstet Gynaecol 21(3):403–409PubMedCrossRef

Hettiarachchi N, Ashbee HR, Wilson JD (2010) Prevalence and management of non-albicans vaginal candidiasis. Sex Transm Infect 86(2):99–100PubMedCrossRef

Hoffstetter SE, Barr S, LeFevre C, Leong FC, Leet T (2008) Self-reported yeast symptoms compared with clinical wet mount analysis and vaginal yeast culture in a specialty clinic setting. J Reprod Med 53(6):402–406PubMed

Hoppe JE (1997) Treatment of oropharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: review and reappraisal. Pediatr Infect Dis J 16(9):885–894PubMedCrossRef

Hoppe JE, Group AS (1997) Treatment of oropharyngeal candidiasis in immunocompetent infants: a randomized multicenter study of miconazole gel vs. nystatin suspension. Pediatr Infect Dis J 16:288–293PubMedCrossRef

Kaufman DA (2008) Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU? Curr Opin Pediatr 20:332–340PubMedCrossRef

Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB (2006) Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J 25:733–737PubMedCrossRef

King CT, Rogers PD, Cleary JD, Chapman SW (1998) Antifungal therapy during pregnancy. Clin Infect Dis 27(5):1151–1160PubMedCrossRef

Kiss H, Petricevic L, Husslein P (2004) Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. BMJ 329(7462):371PubMedCrossRef

Kossoff EH, Buescher ES, Karlowicz MG (1998) Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J 17(6):504–508PubMedCrossRef

Laskus A, Mendling W, Runge K, Schmidt A (1998) Is Candida septicemia in premature infants a nosocomial infection? Mycoses 41(Suppl 2):37–40PubMedCrossRef

de Leon EM, Jacober SJ, Sobel JD, Foxman B (2002) Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2(1):1PubMedCrossRef

Li J, Fan SR, Liu XP, Li DM, Nie ZH, Jin JG, Lin H, Huang WM, Zong LL, Li F et al (2008) Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China. Clin Infect Dis 47(9):1119–1125PubMedCrossRef

Manzoni P, Farina D, Leonessa M, d’Oulx EA, Galletto P, Mostert M, Miniero R, Gomirato G (2006) Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 118:2359–2364PubMedCrossRef

Manzoni P, Monstert M, Agriesti G, Priolo C, Galletto P, Farina D (2007) Neonatal fungal infections: the state of the art. J Chemother 19(Suppl 2):42–45PubMed

Marcinkowski M, Bauer K, Stoltenburg-Didinger G, Versmold H (2001) Fungal brain abscesses in neonates: Sonographic appearances and corresponding histopathologic findings. J Clin Ultrasound 29:417–421PubMedCrossRef

Martinez RC, Franceschini SA, Patta MC, Quintana SM, Candido RC, Ferreira JC, De Martinis EC, Reid G (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48(3):269–274PubMedCrossRef

Mastroiacovo P, Mazzone T, Botto LD, Serafini MA, Finardi A, Caramelli L, Fusco D (1996) Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole. Am J Obstet Gynecol 175(6):1645–1650PubMedCrossRef

Mathema B, Cross E, Dun E, Park S, Bedell J, Slade B, Williams M, Riley L, Chaturvedi V, Perlin DS (2001) Prevalence of vaginal colonization by drug-resistant Candida species in college-age women with previous exposure to over-the-counter azole antifungals. Clin Infect Dis 33(5):E23–27PubMedCrossRef

Mendling W (1995) Vaginose, Vaginitis und Zervizitis. Springer, BerlinCrossRef

Mendling W (2006) Vaginose, Vaginitis, Zervizitis und Salpingitis. Springer, Heidelberg

Mendling W (2010) Die Vulvovaginalkandidose. Leitlinie AWMF 013/004 (S1+IDA)

Mendling W, Spitzbart H (2008) Antimykotische Therapie der vaginalen Hefepilz-Kolonisation von Schwangeren zur Verhütung von Kandidamykosen beim Neugeborenen. AMWF 2008, Guideline 015/042

Mendling W, Krauss C, Fladung B (2004) A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mycoses 47(3–4):136–142PubMedCrossRef

Mendling W, Niemann D, Tintelnot K (2007) Vaginal Colonisation with Candida Species with Special Focus on Candida dubliniensis. Geburtsh Frauenheilk 67:1132–1137CrossRef

Meyer H, Goettlicher S, Mendling W (2006) Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy. Mycoses 49(3):202–209PubMedCrossRef

Neumann G, Kaben U (1971) Einfluß von Östriol, Östradiolbenzoat, Progesteron, Lochialsekret und Fruchtwasser auf das Wachstum von Hefepilzen in vitro. Zentralblatt Gynäkol 93:1147

Neves NA, Carvalho LP, De Oliveira MA, Giraldo PC, Bacellar O, Cruz AA, Carvalho EM (2005) Association between atopy and recurrent vaginal candidiasis. Clin Exp Immunol 142(1):167–171PubMedCrossRef

Nyirjesy P, Seeney SM, Grody MH, Jordan CA, Buckley HR (1995) Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 173(3 Pt 1):820–823PubMedCrossRef

Nyirjesy P, Alexander AB, Weitz MV (2005) Vaginal Candida parapsilosis: pathogen or bystander? Infect Dis Obstet Gynecol 13(1):37–41PubMedCrossRef

Odds FC, Webster CE, Mayuranathan P, Simmons PD (1988) Candida concentrations in the vagina and their association with signs and symptoms of vaginal candidosis. J Med Vet Mycol 26(5):277–283PubMedCrossRef

Ozturk MA, Gunes T, Koklu E, Cetin N, Koc N (2006) Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. Mycoses 49:484–492PubMedCrossRef

Pappu-Katikaneni LD, Rao KP, Banister E (1990) Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses 33(1):20–23PubMed

Paulitsch A, Weger W, Ginter-Hanselmayer G, Marth E, Buzina W (2006) A 5-year (2000–2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses 49(6):471–475PubMedCrossRef

Paulus WE, Lauritzen C (2005) Medikamente und Schadstoffe in Schwangerschaft und Stillzeit. Spitta Verlag, Balingen

Pirotta MV, Gunn JM, Chondros P (2003) "Not thrush again!" Women’s experience of post-antibiotic vulvovaginitis. Med J Aust 179(1):43–46PubMed

Powell BL (1984) Identification of a 173-estradiol-bindig protein in Candida albicans and Candida (Torulopsis) glabrata. Exp Mycology 8:304CrossRef

Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N (2007) Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30(2):312–317PubMedCrossRef

Reed BD, Zazove P, Pierson CL, Gorenflo DW, Horrocks J (2003) Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J Womens Health (Larchmt) 12(10):979–989CrossRef

Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA (2005) Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 43(5):2155–2162PubMedCrossRef

Roberts CL, Rickard K, Kotsiou G, Morris JM (2011) Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial. BMC Pregnancy Childbirth 11(1):18PubMedCrossRef

Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, Blumberg HM, Patterson JE, Rinaldi M, Edwards JE, Wenzel RP, Jarvis W (2000) Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 19:319–324PubMedCrossRef

Schnell JD (1975) Soor bei Schwangeren und Neugeborenen. In: Hartung J, Lubach D (Hrsg) Mykosen. Thieme Verlag, Stuttgart, S 59–66

Schnell JD (1982) Vaginalmykose und perinatale Pilzinfektion. Karger, Basel

Schnell JD (1982) Epidemiology and the prevention of peripartal mycoses. Chemotherapy Subbl 1(28):66–72CrossRef

Schubert B, Seitz CS, Bröcker EB, Hamm H (2007) Exanthematische infantile Psoriasis. JDDG 5:680–682PubMedCrossRef

Shareef MJ, Myers TF, Mathews HL, Witek-Janusek L (1999) Reduced capacity of neonatal lymphocytes to inhibit the growth of Candida albicans. Biol Neonate 75:31–39PubMedCrossRef

Singh S, Sobel JD, Bhargava P, Boikov D, Vasquez JA (2002) Vaginitis due to candida krusei: epidemiology, clinical aspects, and therapy. Clin Inf Dis 35:1066–1070CrossRef

Sobel JD (2005) Current treatment options for vulvovaginal candidiasis. Womens Health (Lond Engl) 1(2):253–261CrossRef

Sobel JD (2007) Vulvovaginal candidosis. Lancet 369(9577):1961–1971PubMedCrossRef

Spinillo A, Capuzzo E, Nicola S, Baltaro F, Ferrari A, Monaco A (1995) The impact of oral contraception on vulvovaginal candidiasis. Contraception 51(5):293–297PubMedCrossRef

Tarry W, Fisher M, Shen S, Mawhinney M (2005) Candida albicans: the estrogen target for vaginal colonization. J Surg Res 129(2):278–282PubMedCrossRef

Wenzl TG, Schefels J, Hornchen H, Skopnik H (1998) Pharmacokinetics of oral fluconazole in premature infants. Eur J Pediatr 157:661–662PubMedCrossRef

Wenzl TG, Skopnik H (2000) Systemische Mykosen. Behandlungsstrategien bei Früh- und Neugeborenen. Pädiatrie hautnah :150–152

Young GL, Jewell D (2000) Topical treatment for vaginal candidiasis in pregnancy. Cochrane Database Syst Rev 2:CD000225PubMed

Titel: Pilzinfektionen
verfasst von: Werner Mendling, Prof. Dr. med.
Ioannis Mylonas
Andreas Schulze, Prof. Dr. med.
Anne Hilgendorff, PD Dr. med.
Verlag: Springer Berlin Heidelberg
Buch: Infektionserkrankungen der Schwangeren und des Neugeborenen
Print ISBN: 978-3-540-78324-4

Electronic ISBN: 978-3-540-78325-1

Copyright-Jahr: 2013
DOI: https://doi.org/10.1007/978-3-540-78325-1_33

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

15.05.2024 Harnwegsinfektionen Nachrichten

Welche Antibiotika darf man bei unkomplizierter Zystitis verwenden und wovon sollte man die Finger lassen? Welche pflanzlichen Präparate können helfen? Was taugt der zugelassene Impfstoff? Antworten vom Koordinator der frisch überarbeiteten S3-Leitlinie, Prof. Florian Wagenlehner.

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

13.05.2024 Gestationsdiabetes Nachrichten

Das Risiko, nach einem Gestationsdiabetes einen Typ-2-Diabetes zu entwickeln, hängt nicht nur von der Zahl, sondern auch von der Reihenfolge der betroffenen Schwangerschaften ab.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

33. Pilzinfektionen

Zusammenfassung

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

Update Gynäkologie

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

S3-Leitlinie zur unkomplizierten Zystitis: Auf Antibiotika verzichten?

Gestationsdiabetes: In der zweiten Schwangerschaft folgenreicher als in der ersten

Update Gynäkologie